Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics, Broad to Study Cancer Genomes

NEW YORK (GenomeWeb News) - Complete Genomics will sequence glioblastoma and melanoma samples for the Broad Institute as part of a pilot study the company announced last month.

For the project, Complete Genomics will use its DNA sequencing technology to sequence five samples provided by the Broad Institute. The first genome will be a sample that has already been studied extensively by the scientific community. The other four genomes will include glioblastoma and melanoma samples and their matched normal controls.

"Our newly-released, proof-of-concept sequencing data have been well received by the scientific community and we are now looking forward to demonstrating our technology's potential to reveal new avenues of medical research," Complete Genomics Chairman, President, and CEO Clifford Reid said in a statement.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.